Available Until 3/23/2023
VIEW CART

Shining a Light on Undiagnosed Nonvalvular Atrial Fibrillation: A Case-based Approach to Care


ACPE Activity Number: 0204-0000-22-410-H01-P
Release Date: March 23, 2022
Expiration Date: March 23, 2023
Activity Type: Application-based
CE Credits: 1.0 contact hour(s) (0.1 CEU)
Activity Fee: Free of charge

 This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

Nonvalvular atrial fibrillation (NVAF) is often undiagnosed and therefore untreated, leaving patients at risk for stroke. Using diverse patient cases, this activity highlights the lack of awareness of NVAF as a potential diagnosis in patients with comorbidities and in underserved communities. Patient cases illustrate the pharmacist’s role in opportunistic and systemic screening for NVAF, working collaboratively among healthcare providers to ensure that patients receive timely guideline-directed therapy, and engaging patients, caregivers, and family members in ongoing contact and therapeutic monitoring that will lead to improved patient outcomes.

More in the Series:

Hidden in Plain Sight: Does My Patient Have Nonvalvular Atrial Fibrillation?

Podcast: 

Finding Hidden Stroke Risk: Screening for Atrial Fibrillation
Listen Now →


Don’t Skip a Beat: Practical Considerations When Choosing an Anticoagulant for Nonvalvular Atrial Fibrillation
Listen Now →

Expert Insight Commentary:

Finding Undiagnosed Atrial Fibrillation: Why, What, Who and How
Read Now →

The Time is Now: Equity in the Prescribing of DOACs for NVAF
Read Now →

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The target audience for this education is pharmacists who care for patients with or at risk for nonvalvular atrial fibrillation.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • List risk factors for nonvalvular atrial fibrillation (NVAF) that should prompt opportunistic screening by the pharmacist.
  • Choose tools for identifying patients with NVAF in a diverse patient population.
  • Apply guidelines in diverse patient populations to improve adherence with patients and their caregivers, particularly in underserved communities.

Schedule of Activities

Welcome and Introductions
James S. Kalus, PharmD, FASHP

Risk Factors for Nonvalvular Atrial Fibrillation
James S. Kalus, PharmD, FASHP

Choosing Screening Tools for Nonvalvular Atrial Fibrillation
James S. Kalus, PharmD, FASHP

Applying the Guidelines to Improve Adherence in Patients with Nonvalvular Atrial Fibrillation
Devin L. Lavender, PharmD, BCPS, BCACP

Faculty Discussion/ Questions and Answers
James S. Kalus, PharmD, FASHP and Devin L. Lavender, PharmD, BCPS, BCACP

Faculty

James S. Kalus, PharmD, FASHP, Activity Chair
Director of Pharmacy
Henry Ford Health System
Detroit, Michigan

James S. Kalus, Pharm.D, FASHP, is Director of Pharmacy at Henry Ford Health System in Detroit, Michigan where he is responsible for planning, implementing, and managing all pharmacy services related to patient care including staff training and development, and pharmacy research. Dr. Kalus also serves as Program Director for the postgraduate year one (PGY1) residency at Henry Ford Hospital and is adjunct assistant professor of pharmacy and medicine at Wayne State University. In his research, Dr. Kalus has focused on cardiovascular disease, including the pathophysiology of atrial fibrillation (AF) occurring after cardiac surgery, novel strategies for the treatment and prevention of AF, practice-based research related to anticoagulation and implementation science related to clinical pharmacy services. 

Devin L. Lavender, PharmD, BCPS, BCACP
Clinical Assistant Professor
University of Georgia College of Pharmacy
Athens, Georgia 

Devin Lavender, Pharm.D., BCPS, BCACP is Clinical Assistant Professor at the University of Georgia College of Pharmacy in Athens, Georgia where he practices in Ambulatory Care and chronic disease management at the Athens Community Based Outpatient Clinic affiliated with the Charlie Norwood VA Medical Center. Dr. Lavender obtained his Pharm.D. degree from The University of Georgia College of Pharmacy. He completed a PGY1 Pharmacy Practice Residency at the Memphis VA Medical Center followed by a PGY2 Ambulatory Care Specialty Residency at the University of Georgia College of Pharmacy in conjunction with the Charlie Norwood VA Medical Center.

Disclosures

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

Provided by ASHP

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance